• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Search within these results
Records Found: 764 Show All Page 1 of 16
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter
764 Rebaudioside D Pending
763 Alpha-lactalbumin Pending
762 Carnobacterium divergens M35 preparation Pending
761 Esterified propoxylated glycerol Pending
760 Lactobacillus curavatus DSM 18775 Pending
759 Steviol glycosides consisting primarily of rebaudioside M produced in Yarrowia lipolytica Pending
758 Lactobacillus helveticus R0052, Bifidobacterium longum ssp. infantis R0033, and Bifidobacterium bifidum R0071 Pending
757 Preparation containing two bacterial phages specific to Escherichia coli O157 Pending
756 Endo-1,4-beta-glucanase from Trichoderma reesei Pending
755 D-psicose Pending
754 Algal oil (87% oleic acid) derived from Prototheca moriformis strain S6697 Pending
753 Sodium thiocyanate Pending
752 Preparation containing the bacterial monophages, BP-63 and LVR16-A, specific to Salmonella Pending
751 Maltogenic alpha-amylase from Bacillus stearothermophilus produced in Bacillus subtilis Pending
750 Beta-glucosidase from Aspergillus niger Pending
749 2’-O-fucosyllactose Pending
748 Tomato powder Pending
747 Calcium lactate Pending
746 Maltogenic amylase from Geobacillus stearothermophilus produced in Bacillus subtilis Pending
745 Steviol glycosides consisting primarily of rebaudioside M Pending
744 Steviol glycosides consisting primarily of rebaudioside M Pending
743 β-galactosidase from Papiliotrema terrestris Pending
742 Duckweed (subfamily Lemnoideae) powder Pending
741 Dimethyl ether Pending
740 Glycolipids from Dacryopinax spathularia Pending
739 Mannanase enzyme from Talaromyces leycettanus produced in Aspergillus niger Pending
738 Thaumatin Pending
737 Soy leghemoglobin Pending
736 Lactobacillus casei subsp. paracasei Lpc-37 Pending
735 2’-Fucosyllactose Pending
734 Ergothionine Pending
733 Purified steviol glycosides Jan 9, 2018 FDA has no questions (in PDF) (69 kB)
732 Docosahexaenoic acid oil produced in Schizochytrium sp. Pending
731 Docosahexaenoic acid oil produced in Schizochytrium sp. Pending
730 Arachidonic acid oil produced in Mortierella alpina Pending
729 Galacto-oligosaccharides Pending
728 Phospholipase C from Pseudomonas sp. 62186 produced in Bacillus licheniformis Nov 13, 2017 FDA has no questions (in PDF) (47 kB)
727 Trehalase from Trichoderma reesei produced in Trichoderma reesei Pending
726 Phenolic preparation from olive fruit Feb 28, 2018 FDA has no questions (in PDF) (66 kB)
725 Inactivated Bacillus coagulans GBI-30, 6086 Feb 12, 2018 FDA has no questions (in PDF) (52 kB)
724 Preparation containing six bacterial phages specific to shiga-toxin producing Escherichia coli Pending
723 Benzalkonium chloride Dec 18, 2017 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (41 kB)
722 Lactobacillus plantarum Lp-115 FDA has no questions (in PDF) (67 kB)
721 Galacto-oligosaccharides Dec 19, 2017 FDA has no questions (in PDF) (69 kB)
720 Rice bran wax Jan 16, 2018 FDA has no questions (in PDF) (73 kB)
719 Orange pomace Dec 26, 2017 FDA has no questions (in PDF) (66 kB)
718 Calcium acid pyrophosphate Oct 17, 2017 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (32 kB)
717 Short-chain fructo-oligosaccharides Feb 13, 2018 FDA has no questions (in PDF) (82 kB)
716 Bovine milk osteopontin Feb 1, 2018 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (32 kB)
715 Rebaudioside D Oct 24, 2017 FDA has no questions (in PDF) (69 kB)

Show All 

jump to page of 16 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter

679661  

-
-